Advertisement

Infektiöse Lebererkrankungen

  • H. Dancygier
  • H. Frühauf
  • C. Sarrazin
  • U. Sarrazin
  • S. Zeuzem
Chapter

Zusammenfassung

Als hepatotrop bezeichnet man Viren, deren primäres Zielorgan die Leber ist. Zu ihnen zählen in erster Linie die Hepatitisviren A, B, C, D und E. Die Bedeutung der „neuen“ Hepatitisviren HGV/GBV-C, TTV und SENV für den Menschen lässt sich derzeit noch nicht vollständig beurteilen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aggarwal R, Krawczynsky K (2000) Hepatitis E. An overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 15: 9–20PubMedGoogle Scholar
  2. Alt M, Renz R, Hofschneider PH et al. (1995) Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 22: 707–717PubMedGoogle Scholar
  3. Bowden S (2001) New hepatitis viruses: contenders and pretenders. J Gastroenterol Hepatol 16: 124–131PubMedGoogle Scholar
  4. Chen PJ (1986) Structure and replication of the genome of hepatitis delta virus. Proc Natl Acad Sci USA 83: 8774–8778PubMedGoogle Scholar
  5. Dienstag JL, Isselbacher JK (1994) Acute hepatitis. In: Isselbacher KJ et al. (eds) Harrison’s principles of internal medicine. McGraw-Hill, New YorkGoogle Scholar
  6. Encke J, zu Putlitz J, Wands JR (1999) DNA vaccines. Intervirology 42: 117–124PubMedGoogle Scholar
  7. Fields DM, Knipe PM, Howley PM (1996) Fields virology, 3rd ed. Lippincott-Raven, PhiladelphiaGoogle Scholar
  8. Hoofnagle JH, Lau D (1997) New therapies for chronic hepatitis B. J Viral Hepatitis 4 [suppl 1]: 41–50Google Scholar
  9. Irshad M (1999) Hepatitis E virus: an update on its molecular, clinical and epidemiological characteristics. Intervirology 42:252–262Google Scholar
  10. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 354: 41–52Google Scholar
  11. Lee J-H, Sarrazin C, Sarrazin U (2000) Experimentelle Therapieansätze bei chronischer Hepatitis Bund C. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, BremenGoogle Scholar
  12. Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337: 1733–1745PubMedGoogle Scholar
  13. Lemon SM (1997) Type A viral hepatitis:epidemiology, diagnosis and prevention. Clinical Chemistry 43: 1494–1499PubMedGoogle Scholar
  14. Mast EE, Alter MJ, Holland PV et al. (1998) Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatology 27: 857–861PubMedGoogle Scholar
  15. Meng XJ, Purcell RH, Halbur PG et al. (1997) A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 94: 9860–9865PubMedGoogle Scholar
  16. Nassal M (1999) Hepatitis B virus replication: novel roles for virus-host interactions. Intervirology 42: 100–116PubMedGoogle Scholar
  17. Pianko S, McHutchison J (1999) Chronic hepatitis B: new therapies on the horizon? Lancet 354: 1662–1663PubMedGoogle Scholar
  18. Rizzetto M (1983) The delta agent. Hepatology 3: 729PubMedGoogle Scholar
  19. Robertson BH, Jansen RW, Khanna B et al. (1992) Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 73: 1365–1377PubMedGoogle Scholar
  20. Robinson WS (1996) Biology of human hepatitis viruses. In: Zakim D, Boyer TD (eds) Hepatology. A textbook of liver disease, 3rd ed. Saunders, PhiladelphiaGoogle Scholar
  21. Sakamoto N, Wu CH, Wu GY (1996) Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes. J Clin Invest 98: 2720–2728PubMedGoogle Scholar
  22. Sarrazin C, Roth WK, Zeuzem S (1998) GB-Virus C/Hepatitis G-Virus-Entdeckung, Epidemiologie, Diagnostik und klinische Relevanz. Z Gastroenterol 36: 997–1008PubMedGoogle Scholar
  23. Sarrazin C, Zeuzem S (2000) Molekular-und Immunbiologie. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, BremenGoogle Scholar
  24. Sarrazin U, Zeuzem S (2000) Therapie der chronischen Hepatitis Bund D. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, BremenGoogle Scholar
  25. Sarrazin U, Sarrazin C (2000) Serologische und molekulare Diagnostik. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, BremenGoogle Scholar
  26. Sjogren MH (1996) Serologie diagnosis of viral hepatitis. Med Clin North Am 80: 929–956PubMedGoogle Scholar
  27. Spangenberg HC, Wands JR (2001) Ribozymes and hepatitis B virus. J Gastroenterol Hepatol 16: 1084–1085PubMedGoogle Scholar
  28. Tarn AW, Smith MM, Guerra ME et al. (1991) Hepatitis E virus (HEV): molecular cloning and sequeneing of the full-Iength viral genome. Virology 185: 120–131Google Scholar
  29. Taylor JM (1999) Hepatitis delta virus. Intervirology 42: 173–178PubMedGoogle Scholar
  30. Tillmann HL, Heiken H, Knapik-Botor A et al. (2001) Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345: 761–762Google Scholar
  31. Totsuka A, Moritsugu Y (1999) Hepatitis A virus proteins. Intervirology 42: 63–68PubMedGoogle Scholar
  32. Von Weizsücker F, Wieland S, Käck J et al. (1997) Gene therapy for chronic viral hepatitis:ribozymes, antisense oligonuc1eotides, and dominant negative mutants. Hepatology 26: 251–255Google Scholar
  33. Zaaijer HL, Ter Borg F, Cuypers HTM et al. (1994) Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol 32: 2088–2091PubMedGoogle Scholar
  34. Zakim D, Boyer TD (eds) (1996) Hepatology, a textbook of liver disease, vol II, 3rd ed. Saunders, PhiladelphiaGoogle Scholar
  35. Zeuzem S (2000) Therapie der chronischen Hepatitis C. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, BremenGoogle Scholar
  36. Zeuzem S, Roth WK, Herrmann G (1995) Virushepatitis C. Z Gastroenterol 33: 117–132PubMedGoogle Scholar
  37. Alter M, Gallagher M, Morris TT et al. (1997) Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 336: 741–746PubMedGoogle Scholar
  38. Altmann HW (1971) Die Histologie der akuten Hepatitis. In: Wannagat L (Hrsg) Die akute Hepatitis. Thieme, Stuttgart, S41–61Google Scholar
  39. Ballardini G, Groff P, Giostra F et al. (1995) Hepatocellular codistribution of c100, c33, c22 and NS 5 hepatitis C virus antigen detected by using immunopurified polyclonal spontaneous antibodies. Hepatology 21: 730–734PubMedGoogle Scholar
  40. Beinker NK, Voigt MD, Arendse M et al. (1996) Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis Band C. J Hepatol 25: 633–638PubMedGoogle Scholar
  41. Bianchi L, de Groote J, Desmet VJ et al. (1971) Morphological criteria in viral hepatitis. Lancet I: 333–337Google Scholar
  42. Blight K, Rowland, Hall PD (1993) Immunohostochemical detection of the NS 4 antigen of hepatitis C virus and its relation to histopathology. Am J Pathol 143: 1568–1573PubMedGoogle Scholar
  43. Boucher E, Bourienne A, Adams P et al. (1997) Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 41: 11 5–120Google Scholar
  44. Boyer JL, Klatskin G (1970) Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic) necrosis. N Engl J Med 283: 1063–1071PubMedGoogle Scholar
  45. Chen TJ, Liaw YF (1988) The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis; a histopathologic study. Liver 8: 10–16PubMedGoogle Scholar
  46. Clouston AD, Jonsson JR, Purdie DM et al. (2001) Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. J Hepatol 34: 314–320PubMedGoogle Scholar
  47. Czaja AJ, Carpenter HA, Santrach PJ et al. (1998) Host-and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 29: 198–206PubMedGoogle Scholar
  48. De Groote J, Desmet VJ, Gedigk T et al. (1968) A classification of chronic hepatitis. Lancet II: 626–628Google Scholar
  49. Desmet VJ, Gerber M, Hoofnagle JH et al. (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513–1520PubMedGoogle Scholar
  50. Dienes HP, Popper H, Arnold W et al. (1982) Histologic observations in human hepatitis non-A, non-B. Hepatology 2: 562–571PubMedGoogle Scholar
  51. Dries V, von Both I, Müller M et al. (1999) Detection of he pat itis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 29: 223–229PubMedGoogle Scholar
  52. Dries V, Odenthal M, Schirmacher P et al. (2001) Bioptische Diagnostik der Hepatitis C. Morphologie, Molekularpathologie und klinisch-therapeutische Implikationen. Pathologe 22:362–368Google Scholar
  53. Fontaine H, Nalpas B, Poulet B et al. (2001) Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C. Hum Pathol 32: 904–909PubMedGoogle Scholar
  54. Foschini MP, Morandi L, Macchia S et al. (2001) TT virus-related acute recurrent hepatitis. Histological features of a case and review of the literature. Virchows Arch 439: 752–755PubMedGoogle Scholar
  55. Foster GR, Goldin RD, Main J et al. (1997) Management of chronic hepatitis C: clinical audit of biopsy based management algorithm. BMJ 315: 453–458PubMedGoogle Scholar
  56. Gerber MA (1998) Pathology of acute viral hepatitis. In: Goldin RD, Thomas HC, Gerber MA (eds) Pathology of viral hepatitis. Arnold, London Sydney Auckland, pp 15–27Google Scholar
  57. Goldin RD, Levine TS, Foster GR et al. (1996) Granulomas and hepatitis C. Histopathology 28: 265–267PubMedGoogle Scholar
  58. Goodman ZD, Ishak KG (1995) Histopathology of hepatitis C infection. Semin Liver Dis 15: 70–81PubMedGoogle Scholar
  59. Gudat F, Bianchi L, Sonnabend W et al. (1975) Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab Invest 32: 1–9PubMedGoogle Scholar
  60. Healey CJ, Chapman RWG, Fleming KA (1995) Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 37: 274–278PubMedGoogle Scholar
  61. Hourigan LF, Macdonald GA, Purdie et al. (1999) Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29: 1215–1219PubMedGoogle Scholar
  62. Hübscher SG (1998) Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 29: 1015–1022PubMedGoogle Scholar
  63. Ikawa H, Hayashi Y, Ninomiya T et al. (2001) Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon. Hum Pathol 32: 910–917PubMedGoogle Scholar
  64. International Working Party (1994) Terminology of chronic hepatitis, hepatic allograft rejection and nodular lesions of the liver: summary and recommendations developed by an international working party, supported by the World Congress of Gastroenterology, Los Angeles, 1994. Am J Gastroenterol 89: S177–181Google Scholar
  65. Ishak KG (1976) Light microscopic morphology of viral hepatitis. Am J Clin Pathol 65: 787–796PubMedGoogle Scholar
  66. Ishak KG (1994) Chronic hepatitis: morphology and nomenclature. Mod Pathol 7: 690–713PubMedGoogle Scholar
  67. Ishak KG, Baptista A, Bianchi L et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22: 696–699PubMedGoogle Scholar
  68. Koukoulis GK (2001) Chronic hepatitis C: grading, staging, and searching for reliable predictors of outcome. Hum Pathol 32: 899–903PubMedGoogle Scholar
  69. Lindh M, Savage K, Rees J et al. (1999) HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B. Liver 19:294–298Google Scholar
  70. Mihm S, Fayyazi A, Hartmann H et al. (1997) Analysis of his topathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 25: 735–739PubMedGoogle Scholar
  71. Miyakawa Y, Mayumi M (1997) Hepatitis G virus — a true hepatitis virus or an accidental tourist? N Engl J Med 336: 795–796PubMedGoogle Scholar
  72. Mochizuki K, Hayashi N, Hiramatsu Net al. (1996) Fas antigen expression im liver tissues of patients with chronic hepatitis B. J Hepatol 24: 1–7PubMedGoogle Scholar
  73. Mosnier JF, Degott C, Marcellin P et al. (1993) The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology 17: 366–371PubMedGoogle Scholar
  74. Park YN, Han KH, Kim KS et al. (1999) Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants. Liver 19: 199–205PubMedGoogle Scholar
  75. Phillips MJ, Poucell S (1981) Modern aspects of the morphology of viral hepatitis. Hum Pathol 12: 1060–1084PubMedGoogle Scholar
  76. Popper H, Paronetto F, Schaffner F (1965) Immune processes in the pathogenesis of liver diseases. Ann NY Acad Sci 124: 781–799PubMedGoogle Scholar
  77. Poulsen H, Christoffersen P (1969) Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis. Acta Path Microbiol Scand 76: 383–390PubMedGoogle Scholar
  78. Rodriguez-Inigo E, Casqueiro M, Bartolome J et al. (2000) Detection of TT virus DNA in liver biopsies by in situ hybridization. Am J Pathol 156: 1227–1234PubMedGoogle Scholar
  79. Rubbia-Brandt L, Quadri R, Abid K et al. (2000) Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 33: 106–115PubMedGoogle Scholar
  80. Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13: 372–374PubMedGoogle Scholar
  81. Schlichting P, Holund B, Poulsen H (1983) Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol 18: 27–32PubMedGoogle Scholar
  82. Sherman KE, Lewey SM, Goodman ZD (1995) Talc in the liver of patients with chronic hepatitis C infection. Am J Gastroenterol 90: 2164–2166PubMedGoogle Scholar
  83. Texeira MR, Weller IV, Murray A et al. (1982) The pathology of hepatitis A in man. Liver 2: 53–60Google Scholar
  84. Zeuzem S, Roth WK, Herrmann G (1995) Virushepatitis C. Z Gastroenterol 33: 117–132PubMedGoogle Scholar
  85. Bader TF (1996) Hepatitis A vaccine. Am J Gastroenterol 91: 217–222PubMedGoogle Scholar
  86. Bekkering FC, Brouwer JT, Leroux-Roels G et al. (1998) Ultra-rapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy. J Hepatol 28: 960–964PubMedGoogle Scholar
  87. Bernstein D, Kleinman L, Barker C et al. (2002) Relationship of health-related quality of life to adherence and sustained response in chronic hepatitis C patients. Hepatology 35: 704–708PubMedGoogle Scholar
  88. Böker KHW, Manns MP (1997) Was bringt die Interferontherapie bei der chronis chen Hepatitis? Internist 38: 191–203Google Scholar
  89. Camma C, Giunta M, Pinzello G et al. (1999) Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol 94: 581–595PubMedGoogle Scholar
  90. Chow WC, Lee ASG, Lim GK et al. (1997) Acute viral hepatitis E: clinical and serologic studies in Singapore. J Clin Gastroenterol 24: 235–238PubMedGoogle Scholar
  91. Czaja AJ (1997) Extrahepatic immunologic features of chronic viral hepatitis. Dig Dis 15: 125–144PubMedGoogle Scholar
  92. Dancygier H, Frühauf H (1997) Klinische Pharmakologie der Leberkrankheiten. In: Kuemmerle (Hrsg) Klinische Pharmakologie, 4. Aufl, Kap. IV-4.11.1. Klinische Pharmakologie der Leberkrankheiten, 53. Erg.-Lfg. 11197. Ecomed, Landsberg/LechGoogle Scholar
  93. Davis GL, Esteban-Mur R, Rustgi V et al. (1998) Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 339: 1493–1499PubMedGoogle Scholar
  94. Foster GR, Finter NB (1998) Are all type I human interferons equivalent? J Viral Hepat 5: 143–152PubMedGoogle Scholar
  95. Glue P, Jane WSF, Rouzier-Panis R et al. (2000) Pegylated interferon-α-2b: pharmacokinetics, pharmacodynamics, safety, and a preliminary efficacy data. Clin Pharmacol Ther 68: 556–567PubMedGoogle Scholar
  96. Häussinger D, Niederau C (Hrsg) (1997) Hepatitis C. Blackwell Wissenschafts-Verlag, BerlinGoogle Scholar
  97. Heathcote J (1998) Consensus interferon: a novel interferon for the treatment of hepatitis C. J Viral Hepat 5 [suppl 1): 13–18PubMedGoogle Scholar
  98. Heathcote EJ, Shiffman ML, Cooksley W et al. (2000) Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 343: 1673–1680PubMedGoogle Scholar
  99. Hopf U, Niederau C, Kleber G et al. (1997) Behandlung der chronischen Virushepatitis B/D und der akuten und chronischen Hepatitis C. Konsensus der Deutschen Gesellschaft för Verdauungs-und Stoffwechselkrankheiten. Z Gastroenterol 35: 971–986PubMedGoogle Scholar
  100. Ikeda K, Saitoh S, Arase Y et al. (1999) Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 29: 1124–1130PubMedGoogle Scholar
  101. Jaeckel E, Cornberg M, Wedemeyer H et al. (2001) Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345: 1452–1457PubMedGoogle Scholar
  102. Koff RS (1998) Hepatitis A. Lancet 241: 1643–1649Google Scholar
  103. Krawczynski K (1993) Hepatitis E. Hepatology 17: 932–941PubMedGoogle Scholar
  104. Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337: 1733–1745PubMedGoogle Scholar
  105. Lemon SM, Thomas DL (1997) Vaccines to prevent viral hepatitis. N Engl J Med 336: 196–204PubMedGoogle Scholar
  106. Lindsay KL, Trepo C, Heintges T et al. (2001) A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 34: 395–403PubMedGoogle Scholar
  107. Lok AS, Heathcote EJ, Hoofnagle JH (2001) Management of hepatitis B: 2000 — summary of a workshop. Gastroenterology 120: 1828–1853PubMedGoogle Scholar
  108. Malik AH, Lee WM (2000) Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann Intern Med 132: 723–731PubMedGoogle Scholar
  109. Manns MP, McHutchison JG, Gordon SC et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958–965PubMedGoogle Scholar
  110. McHutchison JG, Gordon SC, Schiff ER et al. (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339: 1485–1492PubMedGoogle Scholar
  111. Neumann AU, Lam NP, Dahari H et al. (1998) Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282: 103–107PubMedGoogle Scholar
  112. Palmer JP (1997) Treatment of chronic hepatitis C with amantadine. Dig Dis Sci 42(8): 1681–1687Google Scholar
  113. Perry MP, Jarvis B (2001) Peginterferon-α-2a (40kD) A review of its use in the management of chronic hepatitis C. Drugs 61:2263–2288PubMedGoogle Scholar
  114. Poynard T, Marcellin P, Lee SS (1998) Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 352: 1426–1432PubMedGoogle Scholar
  115. Rambusch EG, Manns MP (1998) Extrahepatische Manifestationen der Hepatitis C-Infektion. Z Gastroenterol 36: 579–586PubMedGoogle Scholar
  116. Robert-Koch-Institut (Hrsg) (1999) Zur Situation bei wichtigen Infektionskrankheiten im Jahr 1998 — Teil 2: Virushepatitiden. Epidemiologisches Bulletin 17 199 des Robert-Koch-Institus Berlin vom 30.4.1999, S 119-124Google Scholar
  117. Tillmann HL, Manns MP (2000) Virustatikum für die Therapie der Hepatitis B mit geringem Nebenwirkungsprofil. Arzneimitteltherapie 18: 102–108Google Scholar
  118. Vento S, Garofano T, Renzini C et al. (1998) Fulminant hepatitis associated with hepatitis A superinfection in patients with chronic hepatitis C. N Engl J Med 338: 286–290PubMedGoogle Scholar
  119. Wedemeyer H, Jaeckel E, Wedemeyer J et al. (1998) Ist eine Kombinationstherapie der chronischen Hepatitis C mit Interferon alpha und Ribavirin bei primaren Interferon-Nonrespondern indiziert? — Eine Analyse der eigenen Erfahrungen und eine Zusammenfassung der Literatur. Z Gastroenterol 36: 819–827PubMedGoogle Scholar
  120. Willson RA (1997) Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 92: 4–17Google Scholar
  121. Wu JC, Sheen IJ, Chiang TY et al. (1998) The impact of traveling to endemic areas on the spread of hepatitis E virus infection: epidemiological and molecular analyses. Hepatology 27: 1415–1420PubMedGoogle Scholar
  122. Zeuzem S, Roth WK, Herrmann G (1995) Virushepatitis C. Z Gastroenterol 33: 117–132PubMedGoogle Scholar
  123. Zeuzem S, Feinman SV, Rasenack J (2000) Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343: 1666–1672PubMedGoogle Scholar
  124. Zoulim F, Trepo C (1998) Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. J Hepatol 29: 151–168PubMedGoogle Scholar
  125. Carmichael GP, Zahradnik JM, Moyer GH et al. (1979) Adenovirus hepatitis in an immunsuppressed adult patient. Am J Clin Pathol 71: 352–355PubMedGoogle Scholar
  126. Edington GM, White HA (1972) The pathology of Lassa fever. Trans R Soc Trop Med Hyg 66: 381–389PubMedGoogle Scholar
  127. Edoute Y, Baruch Y, Lachter J et al. (1998) Case report: severe cholestatic jaundice induced by Epstein-Barr virus infection in the elderly. J Gastroenterol Hepatol 13: 821–824PubMedGoogle Scholar
  128. Fabre A, Couvelard A, Degott C et al. (2001) Dengue virus induced hepatitis with chronic calcific changes. Gut 49: 864–865PubMedGoogle Scholar
  129. Fingeroth JD (2000) Herpesvirus infection of the liver. Infect Dis Clin North Am 14: 689–719PubMedGoogle Scholar
  130. Flewett TH, Parker RG, Philip WM (1969) Acute hepatitis due to herpes simplex virus in an adult. J Clin Pathol 22: 60–66PubMedGoogle Scholar
  131. Francis TI, Moore DL, Edington GM et al. (1972) A clinicopathological study of human yellow fever. Bull WHO 46: 659–667PubMedGoogle Scholar
  132. Goodman ZD, Ishak KG, Sesterhenn I (1986) Herpes simplex hepatitis in apparendy immunocompetent adults. Am J Clin Pathol 85: 694–699PubMedGoogle Scholar
  133. Heni N, Heissmeyer HH, Baumgartner M (1986) Klinik der Zytomegalie-Infektion des Erwachsenen. Dtsch Med Wochenschr 111:499–503Google Scholar
  134. Kanno A, Abe M, Yamada M et al. (1997) Clinical and histological features of cytomegalovirus hepatitis in previously healthy adults. Liver 17: 129–132Google Scholar
  135. Kaufman B, Ghandi SA, Louie E et al. (1997) Herpes simplex virus hepatitis: case report and review. Clin Infect Dis 24: 334–338PubMedGoogle Scholar
  136. Kilpatrick ZM (1966) Structural and functional abnormalities of liver in infectious mononucleosis. Arch Intern Med 117: 47–53PubMedGoogle Scholar
  137. Kimura H, Nagasaka T, Hoshino Y et al. (2001) Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes. Hum Pathol 32: 757–762PubMedGoogle Scholar
  138. Klein NA, Mabie WC, Shaver DC et al. (1991) Herpes simplex virus hepatitis in pregnancy. Two patients successfully treated with acyclovir. Gastroenterology 100: 239–244PubMedGoogle Scholar
  139. Krilov LR, Rubin LG, Frogel M et al. (1990) Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states. Rev Infect Dis 12: 303–307PubMedGoogle Scholar
  140. Langnas AN, Markin RS, Cattral MS et al. (1995) Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22: 1661–1665PubMedGoogle Scholar
  141. Lichtenstein PK, Heubi JE, Daugherty CC et al. (1983) Grade I Reye’s syndrome. A frequent cause of vomiting and liver dysfunction after varicella and upper-respiratory-tract infection. N Engl J Med 309: 133–139PubMedGoogle Scholar
  142. Markin RS (1998) Hepatitis from non-hepatotropic viruses. In: Goldin RD, Thomas HC, Gerber MA (eds) Pathology of viral hepatitis. Arnold, London Sydney Auckland, pp 115–138Google Scholar
  143. McLellan RK, Gleiner JA (1982) Acute hepatitis in an adult with rubeola. JAMA 247: 2000–2001PubMedGoogle Scholar
  144. Meng G, Lan Y, Nakagawa M et al. (1997) High prevalence of hantavirus infection in a group of Chinese patients with acute hepatitis of unknown aetiology. J Viral Hep 4: 231–234Google Scholar
  145. Phillips MJ, Blendis LM, Poucell S et al. (1991) Syncytial giantcell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med 324: 455–460PubMedGoogle Scholar
  146. Shaw NJ, Evans JH (1988) Liver failure and Epstein-Barr virus infection. Arch Dis Childhood 63: 432–433Google Scholar
  147. Sun NC, Smith VC (1966) Hepatitis associated with myocarditis: unusual manifestations of infection with coxsackie group B, type 3. N Engl J Med 274: 190–193PubMedGoogle Scholar
  148. Yoto Y, Kudoh T, Haseyama K et al. (1996) Human parvovirus B19 infection associated with acute hepatitis. Lancet 347: 868–869PubMedGoogle Scholar
  149. Adams JS, Walker DH (1981) The liver in Rocky Mountain spotted fever. Am J Clin Pathol 75: 156–161PubMedGoogle Scholar
  150. Altemeier WA, Schowengerdt CG, Whiteley DH (1970) Abscesses of the liver. Surgical considerations. Arch Surg 101: 258–266PubMedGoogle Scholar
  151. Alvarez SZ (1998) Hepatobiliary tuberculosis. J Gastroenterol Hepatol 13: 833–839PubMedGoogle Scholar
  152. Alvarez SZ, Carpio R (1983) Hepatobiliary tuberculosis. Dig Dis Sci 28: 193–200PubMedGoogle Scholar
  153. Chavenet P, Pillon D, Lancon JP et al. (1987) Granulomatous hepatitis associated with Lyme disease. Lancet II: 623–624Google Scholar
  154. Chen C, Chen PJ, Yang PM et al. (1997) Clinical and microbiological features of liver abscess after trans arterial embolization for hepatocellular carcinoma. Am J Gastroenterol 92: 2257–2259PubMedGoogle Scholar
  155. Dan M, Tyrrell LDJ, Goldsand G (1987) Isolation of chlamydia trachomatis from the liver of a patient with prolonged fever. Gut 28: 1514–1516PubMedGoogle Scholar
  156. Dancygier H (1991) Umschriebene Lebererkrankungen (Abszesse, Zysten, Echinokokkose). In: Classen M, Diehl V, Kochsiek K (Hrsg) Innere Medizin. Urban & Schwarzenberg, München Wien Baltimore, S 609–615Google Scholar
  157. De la Vega M, Rivero JC, Su’arez S (2001) A fish bone in the liver. Lancet 358: 982PubMedGoogle Scholar
  158. Diem LV, My TQ, Chi NV et al. (1976) Typhoid fever with hepatitis. J Trop Med Hyg 79: 25–27Google Scholar
  159. Dienes HP (2000) Hepatitis. In: Denk H, Dienes HP, Düllmann J et al. (Hrsg) Pathologie der Leber und der Gallenwege. Springer, Berlin Heidelberg New York, S 317–441Google Scholar
  160. Dugger K, Leby T, Brus M et al. (1990) Hepatic abscess resulting from gastric perforation of a foreign object. Am J Emerg Med 8: 323–325PubMedGoogle Scholar
  161. El-Newihi H, Alamy ME, Reynolds TB (1996) Salmonella hepatitis: analysis of 27 cases and comparison with acute viral hepatitis. Hepatology 24: 516–519PubMedGoogle Scholar
  162. Essop AR, Posen JA, Hodkinson JH et al. (1984) Tuberculous hepatitis. A clinical review of 96 cases. QJM 53: 465–477PubMedGoogle Scholar
  163. Ferreira VA, Vianna MR, Yasuda PH et al. (1987) Detection of leptospiral antigen in the human liver and kidney using an immunoperoxidase staining procedure. J Pathol 151: 125–131Google Scholar
  164. Fogel R, Lewis S (1960) Diagnosis of brucella melitensis infection by percutaneous needle biopsy of the liver. Ann Intern Med 53: 204–215PubMedGoogle Scholar
  165. Gourley GR, Chesney PJ, Davis JP et al. (1981) Acute cholestasis in patients with toxic shock syndrome. Gastroenterology 81: 928–931PubMedGoogle Scholar
  166. Greenstein AJ, Sachar DB (1988) Pyogenic and amebic abscesses of the liver. Semin Liver Dis 8: 210–217PubMedGoogle Scholar
  167. Greenwald KA, Nash G, Foley FD (1969) Acute systemic melioidosis. Autopsy findings in four patients. Am J Clin Pathol 52: 188–198Google Scholar
  168. Horowitz HW, Dworkin B, Forseter G et al. (1996) Liver function in early Lyme disease. Hepatology 23: 1412–1417PubMedGoogle Scholar
  169. Ishak KG, Rogers WA (1981) Cryptogenic acute cholangitis — association with toxic shock syndrome. Am J Clin Pathol 76: 619–626PubMedGoogle Scholar
  170. Judge DM, Samuel I, Perine PL et al. (1974) Louse-born relapsing fever in man. Arch Pathol Lab Med 97: 136–140Google Scholar
  171. Karat ABA, Job CK, Rao PSS (1971) Liver in leprosy: histological and biochemical findings. Br Med J 1(744): 307–310PubMedGoogle Scholar
  172. Khan M, Coovadia Y, Sturm AW (1998) Typhoid fever complicated by acute renal failure and hepatitis: case reports and review. Am J Gastroenterol 93: 1001–1003PubMedGoogle Scholar
  173. Khosla SN (1990) Typhoid hepatitis. Postgrad Med J 66: 923–925PubMedGoogle Scholar
  174. Kimball MW, Knee S (1970) Gonococcal perihepatitis in a male. N Engl J Med 282: 1082–1083PubMedGoogle Scholar
  175. Lam KH, Wong SK, Lee DW et al. (1999) ERCP and pyogenic liver abscess. Gastrointest Endosc 50: 340–344PubMedGoogle Scholar
  176. Leelarasamee A, Bovornkitti S (1989) Melioidosis: review and update. Rev Infect Dis 11: 413–425PubMedGoogle Scholar
  177. Maharaj B, Leary WP, Pudifin DJ (1987) A prospective study of hepatic tuberculosis in 41 black patients. QJM 63: 517–522PubMedGoogle Scholar
  178. Marino P, Maggioni M, Preatoni A et al. (1996) Liver abscesses due to listeria monocytogenes. Liver 16: 67–69PubMedGoogle Scholar
  179. McDonald MI, Corey GR, Gallis HA et al. (1984) Single and multiple pyogenic liver abscesses. Natural history, diagnosis and treatment with emphasis on percutaneous drainage. Medicine (Baltimore) 63: 291–302Google Scholar
  180. Mongiardo N, de Rienzo B, Zonchetta G et al. (1986) Primary hepatic actinomycosis. J Infect 8: 65–69Google Scholar
  181. Ochsner A, De Bakey M, Murray S (1938) Pyogenic abscesses of the liver. II. An analysis of forty-seven cases with review of the literature. Am J Surg 40: 292–319Google Scholar
  182. Piggot JA, Hochholzer L (1970) Human melioidosis. A histopathologic study of acute and chronic melioidosis. Arch Pathol Lab Med 90: 101–111Google Scholar
  183. Pramoolsinsap C, Viranuvatti V (1998) Salmonella hepatitis. J Gastroenterol Hepatol 13: 745–750PubMedGoogle Scholar
  184. Putnam HC, Dockerty MB, Waugh JM (1950) Abdominal actinomycosis. Surg 28: 781–800Google Scholar
  185. Rajak CL, Gupta S, Jain S et al. (1998) Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage. Am J Roentgenol 170: 1035–1039Google Scholar
  186. Seeto RK, Rockey DC (1996) Pyogenic liver abscess. Changes in etiology, management, and outcome. Medicine (Baltimore) 75: 99–113Google Scholar
  187. Srinivasan A, Kraus CN, DeShazer D et al. (2001) Glanders in a military research microbiologist. N Engl J Med 345: 256–258PubMedGoogle Scholar
  188. Steere AC, Bartenhagen NH, Craft JE et al. (1983) The earlyclinical manifestations of Lyme disease. Ann Intern Med 99: 76–82PubMedGoogle Scholar
  189. Tazawa J, Sakai Y, Maekawa S et al. (1997) Solitary and multiple pyogenic liver abscesses: characteristics of the patients and efficacy of percutaneous drainage. Am J Gastroenterol 92: 271–274PubMedGoogle Scholar
  190. Weil A (1886) Über eine eigentümliche mit Milztumor, Icterus und Nephritis einhergehende akute Infektionskrankheit. Dtsch Arch Klin Med 39: 209Google Scholar
  191. Williams RK, Crossley K (1982) Acute and chronic hepatic involvement of brucellosis. Gastroenterology 83: 455–458PubMedGoogle Scholar
  192. Yang CC, Chen CY, Lin XZ et al. (1993) Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics. Am J Gastroenterol 88: 1911–1915PubMedGoogle Scholar
  193. Yu VL, Miller WP, Wing EJ et al. (1982) Disseminated listeriosis presenting as acute hepatitis. Am J Med 73: 773–777PubMedGoogle Scholar
  194. Badalamenti S, Jameson JE, Reddy KR (1999) Amebiasis. Curr Treat Opt Gastroenterol 1: 97–103Google Scholar
  195. Crane GG (1986) Hyperreactive malarious splenomegaly (tropical splenomegaly syndrome). Parasitol Today 2: 4–9PubMedGoogle Scholar
  196. Greenstein AJ, Sachar DB (1988) Pyogenic and amebic abscesses of the liver. Semin Liver Dis 8: 210–217PubMedGoogle Scholar
  197. Knight R (1984) Hepatic amebiasis. Semin Liver Dis 4: 277–292PubMedGoogle Scholar
  198. Li E, Stanley SL (1996) Amebiasis. Gastroenterol Clin North Am 25: 47l–492Google Scholar
  199. Pampiglione S, Manson-Bahr PEC, Giungi F et al. (1974) Studies in mediterranean leishmaniasis 2. Asymptomatic cases of visceral leishmaniasis. Trans R Soc Trop Med Hyg 68: 447–453PubMedGoogle Scholar
  200. Pradel G, Frevert U (2001) Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion. Hepatology 33: 1154–1165PubMedGoogle Scholar
  201. Reed SL (1992) Amebiasis: an update. Clin Infect Dis 14: 385–393PubMedGoogle Scholar
  202. Sharma MP, Dasarathy S, Verma N et al. (1996) Prognostic markers in amebic liver abscess: a prospective study. Am J Gastroenterol 91: 2584–2588PubMedGoogle Scholar
  203. Teutzner KH, Treumann T, Winkeltau G et al. (1989) Die parasitäre Leberzyste. Leber Magen Darm 19: 111–124Google Scholar
  204. Tiwari I, Roland CF, Popple AW (1982) Cholestatic jaundice due to toxoplasma hepatitis. Postgrad Med J 58: 299–300PubMedGoogle Scholar
  205. Turrini F, Schwarzer E, Arese P (1993) The involvement of hemozoin toxicity in depression of cellular immunity. Parasitol Today 9: 297–300PubMedGoogle Scholar
  206. Weitberg AB, Alper JC, Diamond I et al. (1979) Acute granulomatous hepatitis in the course of acquired toxoplasmosis. N Engl J Med 300: 1093–1096PubMedGoogle Scholar
  207. Aktan AÖ, Yalin R (1996) Preoperative albendazole treatment for liver hydatid disease decreases the viability of the cyst. Eur J Gastroenterol 8: 877–879Google Scholar
  208. Andrade ZA, Peixoto E, Guerret S et al. (1992) Hepatic connective tissue changes in hepatosplenic schistosomiasis. Hum Pathol 23: 566–573PubMedGoogle Scholar
  209. Bastid C, Azar C, Doyer M et al. (1994) Percutaneous treatment of hydatid cysts under sonographic guidance. Dig Dis Sci 39: 1576–1580PubMedGoogle Scholar
  210. Beaver PC (1969) The nature of visceral larva migrans. J Parasitol 55: 3–12PubMedGoogle Scholar
  211. Bhatia V, Sarin SK (1994) Hepatic visceral larva migrans: evolution of the lesion, diagnosis, and role of high-dose albendazole therapy. Am J Gastroenterol 89: 624–627PubMedGoogle Scholar
  212. Bica I, Hamer DH, Stadecker MJ (2000) Hepatic schistosomiasis. Infect Clin North Am 14: 583–604Google Scholar
  213. Camacho-Lobato L, Borges DR (1998) Early liver dysfunction in schistosomiasis. J Hepatol 29: 233–240PubMedGoogle Scholar
  214. Chen MG, Mott KE (1990) Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull 87: Rl–37Google Scholar
  215. Dessein AJ, Hillaire D, Eldin N et al. (1999) Severe hepatic fibrosis in schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 65: 709–721PubMedGoogle Scholar
  216. Dovidar N, El Sayad M, Mervat O et al. (1999) Endoscopic therapy of fascioliais resistant to oral therapy. Gastrointest Endosc 50: 345–351Google Scholar
  217. Frider B, Larrieu E, Odriozola M (1999) Long-term outcome of asymptomatic liver hydatidosis. J Hepatol 30: 228–231PubMedGoogle Scholar
  218. Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG et al. (1993) Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 342: 1269–1272PubMedGoogle Scholar
  219. Goldring OL, Klegg JA, Smithers SR et al. (1976) Acquisition of human blood group antigens by schistosoma mansoni. Clin Exp Immunol 26: 181–187PubMedGoogle Scholar
  220. Hernandez HJ, Wang Y, Tzellas N et al. (1997) Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with schistosoma mansoni. Eur J Immunol 27: 1170–1176PubMedGoogle Scholar
  221. Hira PR, Lindberg LG, Francis I et al. (1988) Diagnosis of cystic hydatid disease: role of aspiration cytology. Lancet II: 655–657Google Scholar
  222. Hou PC (1955) The pathology of clonorchis sinensis infestation of the liver. J Pathol 70: 53–64Google Scholar
  223. Ishizu H, Uchino J, Sato N et al. (1997) Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery. Hepatology 25: 528–531PubMedGoogle Scholar
  224. Kaul V, Friedenberg F, Rothstein KD (2000) Hepatic cysts. Curr Treat Opin Gastroenterol 3: 349–343Google Scholar
  225. Kern P, Kratzer W, Reuter S (2000) Alveoläre Echinokokkose: Diagnostik. Dtsch Med Wochenschr 125: 59–62PubMedGoogle Scholar
  226. Kern P, Kratzer W, Reuter S (2000) Alveoläre Echinokokkose: Therapie. Dtsch Med Wochenschr 125: 87–89PubMedGoogle Scholar
  227. Khuroo MS, Wani NA, Javid G et al. (1997) Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med 337: 881–887PubMedGoogle Scholar
  228. Liu LX, Harinasuta KT (1996) Liver and intestinal flukes. Gastroenterol Clin North Am 25: 627–636PubMedGoogle Scholar
  229. MacLean JD, Graeme-Cook FM (2002) A 50-year-old man with eosinophilia and fluctuating hepatic lesions. N Engl J Med 346: 1232–1239PubMedGoogle Scholar
  230. Miguet JP, Bresson-Hadni S (1989) Alveolar echinococcosis of the liver. J Hepatol 3: 373–379Google Scholar
  231. Samuelson JC, Sher A, Caulfield JP (1980) Newly transformed schistosomula spontaneously lose surface antigens and C3 acceptor sites during culture. J Immunol 124: 2055–2057PubMedGoogle Scholar
  232. Schantz PM, Glickman LT (1978) Toxocaral visceral larva migrans. N Engl J Med 298: 436–439PubMedGoogle Scholar
  233. Simpson AJ, Singer D, McCutchan TF et al. (1983) Evidence that schistosome MHC antigens are not synthesized by the parasite but are acquired from the host as intact glycoproteins. J Immunol 131: 962–965PubMedGoogle Scholar
  234. Teutzner KH, Treumann T, Winkeltau G et al. (1989) Die parasitare Leberzyste. Leber Magen Darm 19: 111–124Google Scholar
  235. Üstünsöz B, Akhan O, Kamiloglu MA et al. (1999) Percutaneous treatment of hydatid cysts of the liver: long term results. Am J Radiol 172: 91–96Google Scholar
  236. Warren KS, Domingo EO (1970) Granuloma formation around schistosoma mansoni, S. haematobium and S. japonicum eggs. Site and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am J Trop Med Hyg 19: 292–304PubMedGoogle Scholar
  237. Wilson JF, Rausch RL, Wilson FR (1995) Alveolar hydatid disease. Review of the surgical experience in 42 cases of active disease among Alaskan Eskimos. Ann Surg 221: 315–323PubMedGoogle Scholar
  238. Goodwin RA, Shapiro JL, Thurman GH et al. (1980) Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 59: 1–33Google Scholar
  239. Jain R, McLaren B, Bejarano P et al. (1996) Diagnostic problem in clinical hepatology. A 69-year-old man with cholestatic liver disease. Semin Liver Dis 16: 445–449PubMedGoogle Scholar
  240. Redding PA, Gorelick DF, Brasher CA et al. (1970) Progressive disseminated histoplasmosis seen in adults. Am J Med 48: 629–636Google Scholar
  241. Thaler M, Pastakia B, Shawker TH et al. (1988) Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 108: 88–100PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • H. Dancygier
  • H. Frühauf
  • C. Sarrazin
  • U. Sarrazin
  • S. Zeuzem

There are no affiliations available

Personalised recommendations